Study

Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy. – Cost Effective Supplements

Creatine monohydrate in DM2/PROMM: a double-blind placebo-controlled clinical study. Proximal myotonic myopathy.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/12578937


Conclusion of this study

Twenty patients received either Cr or placebo for 3 months. After 3 months, there were no significant differences of muscle strength as assessed by hand-held dynamometry, testing of maximum grip strength, Medical Research Council scoring, and the Neuromuscular Symptom Score between the two groups. Some measures indicated trends toward mild improvement with Cr. Myalgia improved in two patients.


Supplements analyzed in this study

Creatine

Health conditions analyzed in this study

Fatigue


Moderately Positive
Creatine

Myotonic Dystrophy


Slightly Positive
Creatine


Functions related to this study

Energy


Moderately Positive
Creatine

Muscle building


Highly Positive
Creatine

Overall health


Slightly Positive
Creatine


Body systems related to this study


Muscular System

Nervous System
Scroll to top